ValiRx plc (LON:VAL – Get Free Report)’s stock price rose 17.9% during trading on Friday . The stock traded as high as GBX 0.68 ($0.01) and last traded at GBX 0.68 ($0.01). Approximately 2,650,703 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 5,183,082 shares. The stock had previously closed at GBX 0.58 ($0.01).
ValiRx Stock Up 13.0%
The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27. The firm has a 50-day simple moving average of GBX 0.59 and a 200 day simple moving average of GBX 0.56. The company has a market capitalization of £2.43 million, a PE ratio of -44.83 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its earnings results on Friday, June 6th. The company reported GBX (1.45) EPS for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. On average, research analysts predict that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Recommended Stories
- Five stocks we like better than ValiRx
- How to Calculate Options Profits
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
- How to Start Investing in Real Estate
- Engines to AI: Cummins’ Surprising Growth Driver
- Stock Splits, Do They Really Impact Investors?
- Smaller Industrials Names Seeing Surging Growth: Here’s Why
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
